FCM
IRWD icon

Farallon Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Farallon Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.6K Hold
13,000
– – ﹤0.01% 168
2025
Q4 		$43.8K Hold
13,000
– – ﹤0.01% 150
2025
Q3 		$17K Hold
13,000
– – ﹤0.01% 144
2025
Q2 		$9.32K Hold
13,000
– – ﹤0.01% 145
2025
Q1 		$19.1K Hold
13,000
– – ﹤0.01% 144
2024
Q4 		$57.6K Hold
13,000
– – ﹤0.01% 146
2024
Q3 		$53.6K Hold
13,000
– – ﹤0.01% 154
2024
Q2 		$84.8K Hold
13,000
– – ﹤0.01% 150
2024
Q1 		$113K Buy
+13,000
New +$158K ﹤0.01% 157

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Farallon Capital Management's IRWD Position: Q1 2026 in Review

Farallon Capital Management held its Ironwood Pharmaceuticals (IRWD) position steady in Q1 2026 at 13,000 shares worth $45.6K. The position accounts for ﹤0.01% of the portfolio, ranked #168.

Farallon Capital Management first reported a position in IRWD in Q1 2024 and has held it in 9 quarters since. The position peaked at $113K in Q1 2024. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Farallon Capital Management held 13,000 shares of Ironwood Pharmaceuticals worth $45.6K as of Q1 2026.
  • Farallon Capital Management left its Ironwood Pharmaceuticals share count unchanged in Q1 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Farallon Capital Management's portfolio in Q1 2026, its #168 holding.
  • Farallon Capital Management first reported a position in Ironwood Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • Farallon Capital Management's Ironwood Pharmaceuticals position peaked at $113K in Q1 2024.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Farallon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.